Daryl Geers

2.1k total citations
15 papers, 144 citations indexed

About

Daryl Geers is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Daryl Geers has authored 15 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Health and 4 papers in Epidemiology. Recurrent topics in Daryl Geers's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Vaccine Coverage and Hesitancy (5 papers). Daryl Geers is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Vaccine Coverage and Hesitancy (5 papers). Daryl Geers collaborates with scholars based in Netherlands, United States and Canada. Daryl Geers's co-authors include Belinda Baquero-Pérez, Juana Díez, Rory D. de Vries, Corine H. GeurtsvanKessel, Debbie van Baarle, Roos S. G. Sablerolles, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Anke Huckriede and Marion Koopmans and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Daryl Geers

13 papers receiving 143 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daryl Geers Netherlands 5 93 45 34 19 18 15 144
Aracelly Gaete-Argel Chile 8 71 0.8× 98 2.2× 10 0.3× 15 0.8× 23 1.3× 15 174
Ke Lin China 7 42 0.5× 28 0.6× 15 0.4× 16 0.8× 13 0.7× 11 98
Weixue Si China 2 136 1.5× 44 1.0× 36 1.1× 40 2.1× 35 1.9× 3 193
Gina Cusimano United States 4 66 0.7× 57 1.3× 11 0.3× 7 0.4× 54 3.0× 5 134
Yuezhou Chen United States 6 103 1.1× 50 1.1× 13 0.4× 8 0.4× 62 3.4× 8 158
Lydia Riepler Austria 7 202 2.2× 41 0.9× 5 0.1× 24 1.3× 24 1.3× 11 263
Kathy Stephens United States 8 87 0.9× 110 2.4× 8 0.2× 19 1.0× 18 1.0× 10 209
Julie Eggenberger United States 5 132 1.4× 49 1.1× 17 0.5× 18 0.9× 76 4.2× 6 191
Sebastian Einhauser Germany 8 121 1.3× 31 0.7× 15 0.4× 12 0.6× 21 1.2× 14 146
Katharina Grikscheit Germany 6 271 2.9× 93 2.1× 29 0.9× 24 1.3× 48 2.7× 10 314

Countries citing papers authored by Daryl Geers

Since Specialization
Citations

This map shows the geographic impact of Daryl Geers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daryl Geers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daryl Geers more than expected).

Fields of papers citing papers by Daryl Geers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daryl Geers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daryl Geers. The network helps show where Daryl Geers may publish in the future.

Co-authorship network of co-authors of Daryl Geers

This figure shows the co-authorship network connecting the top 25 collaborators of Daryl Geers. A scholar is included among the top collaborators of Daryl Geers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daryl Geers. Daryl Geers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Zaeck, Luca M., Renske Schappin, Daryl Geers, et al.. (2024). Polysaccharide, Conjugate, and mRNA-based Vaccines are Immunogenic in Patients with Netherton Syndrome. Journal of Clinical Immunology. 45(1). 36–36. 1 indexed citations
3.
Schmitz, Katharina S., Linda J. Rennick, Natasha L. Tilston‐Lunel, et al.. (2024). Rational attenuation of canine distemper virus (CDV) to develop a morbillivirus animal model that mimics measles in humans. Journal of Virology. 98(3). e0185023–e0185023.
4.
Geers, Daryl, Rory D. de Vries, Corine H. GeurtsvanKessel, et al.. (2024). Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands. AIDS. 38(9). 1355–1365. 2 indexed citations
5.
Geers, Daryl, Lennert Gommers, Luca M. Zaeck, et al.. (2024). Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants. Journal of Infection. 89(4). 106246–106246. 2 indexed citations
6.
Geers, Daryl, Wim J. R. Rietdijk, Lennert Gommers, et al.. (2024). The effect of sleep and shift work on the primary immune response to messenger RNA ‐based COVID ‐19 vaccination. Journal of Sleep Research. 34(4). e14431–e14431. 1 indexed citations
7.
Laksono, Brigitta M., Anouskha D. Comvalius, Katharina S. Schmitz, et al.. (2023). Infection of ferrets with wild type-based recombinant canine distemper virus overwhelms the immune system and causes fatal systemic disease. mSphere. 8(4). 4 indexed citations
8.
Schmitz, Katharina S., Anouskha D. Comvalius, Nella J. Nieuwkoop, et al.. (2023). A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial. Vaccine. 41(43). 6495–6504. 3 indexed citations
9.
Schmitz, Katharina S., Daryl Geers, Rory D. de Vries, et al.. (2022). Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern. mBio. 13(3). e0124922–e0124922. 14 indexed citations
10.
Sablerolles, Roos S. G., Wim J. R. Rietdijk, Abraham Goorhuis, et al.. (2022). Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers. Clinical Infectious Diseases. 76(3). e533–e536. 7 indexed citations
11.
Sablerolles, Roos S. G., Wim J. R. Rietdijk, Abraham Goorhuis, et al.. (2022). Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol. Frontiers in Immunology. 13. 1067749–1067749. 2 indexed citations
12.
13.
Dieterich, M., Daryl Geers, Marcia M. L. Kho, et al.. (2022). 330.2: T-Cell Cytokine Profiles After mRNA-1273 COVID-19 Vaccination in Kidney Patients. Transplantation. 106(9S). S261–S261. 1 indexed citations
14.
Sablerolles, Roos S. G., Wim J. R. Rietdijk, Abraham Goorhuis, et al.. (2022). Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming. New England Journal of Medicine. 386(10). 951–963. 64 indexed citations
15.
Baquero-Pérez, Belinda, Daryl Geers, & Juana Díez. (2021). From A to m6A: The Emerging Viral Epitranscriptome. Viruses. 13(6). 1049–1049. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aracelly Gaete-Argel Breakdown of academic impact, for papers by Ke Lin Breakdown of academic impact, for papers by Weixue Si Breakdown of academic impact, for papers by Gina Cusimano Breakdown of academic impact, for papers by Yuezhou Chen Breakdown of academic impact, for papers by Lydia Riepler Breakdown of academic impact, for papers by Kathy Stephens Breakdown of academic impact, for papers by Julie Eggenberger Breakdown of academic impact, for papers by Sebastian Einhauser Breakdown of academic impact, for papers by Katharina Grikscheit
Rankless by CCL
2026